Jun 27, 2024 Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape Learn More
May 29, 2024 Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides Learn More
May 14, 2024 Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update Learn More
May 8, 2024 Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day Learn More